Selected Papers
Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder
Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, and Tauscher J
BIOL PSYCHIATRY 2007;61:1081-1089, 2010 IF 8.674
|
Reward and the Serotonergic System Kranz GS, Kasper S, Lanzenberger R Neuroscience 2010 Apr 14;166(4):1023-1035. Epub 2010 Jan 28, 2010 IF: 3.215 |
|
|
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder
Hahn A*, Stein P*, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R.
*contributed equally
Neuroimage. 2011 Jun 1;56(3):881-9. Epub 2011 Feb 26, 2010 IF 5.932
Escitalopram attenuates amygdala reactivity to emotional processing as revealed by pharmacological fMRI at 3T
Windischberger C*, Lanzenberger R*, Stein P, Holik A, Spindelegger C, Moser U, Gerstl F, Fink M, Moser E, Kasper S
*contributed equally
NeuroImage 2010 Jan 15;49(2):1161-70. Epub 2009 Oct 13, 2010 IF 5.932
Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders
Spindelegger C*, Lanzenberger R*, Wadsak W, Mien LK, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S
*contributed equally
Molecular Psychiatry 2009 Nov;14(11):1040-50. Epub 2008 Mar 25, 2010 IF 15.47
Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET
Gerstl F, Windischberger C, Mitterhauser M, Wadsak W, Holik A, Kletter A, Moser E, Kasper S, and Lanzenberger R
NeuroImage 41 (2008) 204-211, 2010 IF 5.932
|
The Serotonin-1A receptor in Anxiety disorders Akimova E, Lanzenberger R, Kasper S Biological Psychiatry 2009 Oct; 66:627-635, Epub 2009 May 7, 2010 IF 8.674 |
|
|
Cortisol plasma levels in Social Anxiety Disorder patients correlate with serotonin-1A receptor binding in limbic brain regions
Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien LK, Fink M, Moser U, Savli M, Kranz SG, Hahn A, Kletter K, Kasper S
International Journal of Neuropsychopharmacology, Epub 2010 Jun 2, 2010 IF 4.699
NeuroImaging bei schizophrenen Erkrankungen
Rupert R. Lanzenberger, Siegfried Kasper
Fortschr Neurol Psychiatr. 2005 Nov; 73 Suppl 1:51-59, 2010 IF 0.652
The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling
Christian H. Kasess, Christian Windischberger, Ross Cunnington, Rupert R. Lanzenberger, Lukas Pezawas, Ewald Moser
NeuroImage 40 (2008) 828-837, 2010 IF 5.932
Papers
Escitalopram enhances the association of serotonin-1A auto- to heteroreceptors in anxiety disorders
Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien LK, Mitterhauser M, Kasper S.
Journal of Neuroscience, J Neurosci. 2010 Oct 27;30(43):14482-9, 2010 IF 8.068
Progesterone and serotonergic neurotransmission in the human brain
Lanzenberger R, Mitterhauser M, Kranz GS, Spindelegger C, Wadsak W, Stein P, Moser U, Kletter K, Kasper S.
Neuroendocrinology 2011, in press, 2010 IF 3.272
Model-free fMRI group analysis using FENICA
Schöpf V, Windischberger C, Robinson S, Kasess CH, Fischmeister FP, Lanzenberger R, Albrecht J, Kleemann AM, Kopietz R, Wiesmann M, Moser E.
Neuroimage 2011 Mar 1;55(1):185-93. Epub 2010 Nov 13, 2010 IF 5.932
Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women
Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien LK, Bieglmayer C, Kletter K, Kasper S, Lanzenberger R
Neuroscience Letters 2010 Jun 7;476(3):161-5. Epub 2010 Apr 22, 2010 IF 2.055
Fully Explorative Network ICA (FENICA) on resting-state fMRI data.
Schoepf V, Kasess CH, Lanzenberger R, Fischmeister F, Windischberger C, Moser E.
Journal of Neuroscience Methods, Epub 2010 Aug 2, 2010 IF 2.262
Group ICA analysis of resting-state data: a quantitative comparison
Schoepf V, Windischberger C, Kasess CH, Lanzenberger R, Moser E
MAGMA Magnetic Resonance Materials in Physics, Biology and Medicine, Epub 2010 Jun 3, 2010 IF 2.373
Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-(11)C]WAY-100635 PET study
Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien LK, Stögmann E, Baumgartner C, Kletter K, Asenbaum S
Epilepsy Behav., Epub 2010 Sep 15, 2010 IF 1.994
Microfluidic Preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2 -- comparison with conventional radiosyntheses
Ungersboeck J, Philippe C, Mien LK, Haeusler D, Shanab K, Lanzenberger R, Spreitzer H, Keppler B, Dudczak R, Kletter K, Mitterhauser M, Wadsak W.
Nuclear Medicine and Biology, 2011 Apr;38(3):427-34. Epub 2010 Dec 3, 2010 IF 2.62
Social Anxiety Disorder: Epidemiology, Biology and Treatment
Fink M, Akimova E, Spindelegger C, Hahn A, Lanzenberger R, Kasper S
Psychiatria Danubina 2009 Dec;21(4):533-42, 2010 IF 0.554
[18F]FE@SUPPY and [18F]FE@SUPPY:2 - Metabolic considerations
Haeusler D, Nics L, Mien LK, Ungersboeck J, Lanzenberger R, Shanab K, Sindelar KM, Viernstein H, Wagner KH, Dudczak R, Kletter K, Wadsak W, Mitterhauser M
Nuclear Medicine and Biology 2010 May;37(4):421-6. Epub 2010 Mar 6, 2010 IF 2.62
Aggression is related to frontal serotonin-1A receptor distribution revealed by positron emission tomography
Witte V, Flöel A, Stein P, Savli M, Mien LK, Wadsak W, Spindelegger C, Moser U, Fink M, Hahn A, Mitterhauser M, Kletter K, Kasper S, Lanzenberger R
Human Brain Mapping 2009 Aug;30(8):2558-70; Epub 2008 Dec 11, 2010 IF 5.107
Lateralization of the serotonin-1A receptor distribution in language areas is associated with sex
Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A, Mien LK, Kletter K, Mitterhauser M, Kasper S, Lanzenberger R
NeuroImage 2009 Apr 1;45(2):598-605; Epub 2008 Dec 9, 2010 IF 5.932
Network Atrophy in Temporal Lobe Epilepsy - A Voxel-based Morphometry (VBM) Study
Riederer F, Lanzenberger R, Kaya M, Prayer D, Serles W, Baumgartner C
Neurology 2008 Aug 5;71(6):419-25; 2010 IF 8.017
Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain
Witte VA, Savli M, Holik A, Kasper S, Lanzenberger R
NeuroImage 2010 Jan 15;49(2):1205-12, Epub 2008 Sept 28; 2010 IF 5.932
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635
Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien LK, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R.
Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2159-68. Epub 2008 Jun 10; 2010 IF 5.036
Correlations and Anticorrelations in Resting-State Functional Connectivity MRI: A Quantitative Comparison of Preprocessing Strategies
Weissenbacher A, Kasess C, Gerstl F, Lanzenberger R, Moser E, Windischberger C
NeuroImage 2009 Oct 1;47(4):1408-16; Epub 2009 May 13; 2010 IF 5.932
Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications
D. Haeusler, L.-K. Mien, L. Nics, J. Ungersboeck, C. Philippe, R.R. Lanzenberger, K. Kletter, R. Dudczak, M. Mitterhauser, W. Wadsak
Applied Radiation and Isotopes 2009; Mar 20. [Epub ahead of print]; 2010 IF 0.999
Differences in the dynamics of SERT occupancy may explain superior clinical efficacy of escitalopram versus citalopram
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R
Int Clin Psychopharmacol. 2009 May;24(3):119-25; 2010 IF 2.762
Preparation and first evaluation of [18F]FE@SUPPY: a new PET-Tracer for the Adenosine A3 Receptor
Wadsak W, Mien LK, Shanab K, Ettlinger DE, Haeusler D, Sindelar K, Lanzenberger R, Spreitzer H, Viernstein H, Keppler BK, Dudczak R, Kletter K, Mitterhauser M
Nuclear Medicine and Biology 2008; 35:61-66; 2010 IF 2.62
Time-resolved Analysis of fMRI signal changes using Brain Activation Movies
Windischberger W, Cunnington R, Lamm C, Lanzenberger R, Langenberger H, Deecke L, Bauer H, Moser E
Journal of Neuroscience Methods 2007 Dec 14; 2010 IF 2.262
Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP
Mitterhauser M, Toegel S, Wadsak W, Lanzenberger R, Mien LK, Kuntner C, Wanek T, Harald Eidherr H, Ettlinger DE, Viernstein H, Kluger R, Dudczak R, Kletter K
Nuclear Medicine and Biology 2007 May; 34(4):391-397; 2010 IF 2.62
Preparation and radiosynthesis of [18F]FE@CFN (2-[18F]fluoroethyl 4-[N-(1- oxopropyl)-N-phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate): a potential μ- opioid receptor imaging agent
Wadsak W, Mien LK, Ettlinger DE, Feitscher S, Lanzenberger R, Marton J, Dudczak R, Kletter K, Mitterhauser M
Radiochimica Acta 2007, 95, 33-38; 2010 IF 1.128
Simple and fully automated preparation of [carbonyl-11C]WAY-100635
Wadsak W, Mien LK, Ettlinger DE, Lanzenberger R, Haeusler D, Dudczak R, Kletter K, Mitterhauser M
Radiochimica Acta 2007, 95, 1-6; 2010 IF 1.128
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and Alzheimer's disease patients
Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Aiman A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado M, Lods N, Dudczak R, Auff E, Kletter K, Müller M
Clinical Pharmacology and Therapeutics 2006 Sep; 80(3):216-227; 2010 IF 6.378
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
Klein N, Sacher J, Geiss-Granadia T, Mossaheb N, Attarbaschi T, Lanzenberger R, Spindelegger C, Holik A, Asenbaum S, Dudczak R, Tauscher J, Kasper S
Psychopharmacology (Berl). 2007 Jan 19; [Epub ahead of print]; 2010 IF 3.817
Striatal D2 receptor occupancy in bipolar patients treated with olanzapine
Attarbaschi T, Sacher J, Geiss-Granadia T, Klein N, Mossaheb N, Wiesegger G, Lanzenberger R, Asenbaum S, Dudczak R, Doby D, Kasper S, Tauscher J
European Neuropsychopharmacology 2007 Feb; 17(2):102-7; 2010 IF 4.201
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy volunteers treated different doses of escitalopram or citalopram
Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Pötzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S
Psychopharmacology (Berl). 2006 Oct; 188(3):263-72; 2010 IF 3.817
Binding kinetics of 123 I[ADAM] in healthy controls: a selective SERT radioligand
Sacher J, Asenbaum S, Klein N, Geiss-Granadia T, Mossaheb N, Pötzi C, Attarbaschi T, Lanzenberger R, Spindelegger C, Rabas A, Heinze G, Dudczak R, Kasper S, Tauscher J
Int J Neuropsychopharmacol. 2006 Feb 17;1-8; 2010 IF 4.699
FMRI of the emotions: towards an improved understanding of amygdala function
Robinson S, Hoheisel B, Windischberger C, Habel U, Lanzenberger R, Moser E
Current Medical Image Review (CMIR) 2005; Vol. 1(2): 115-129, 2010 IF 0.476
Evaluation of preoperative high field motor functional- MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome
Roessler K, Donat M, Lanzenberger R, Novak K, Geissler A, Gartus A, Tahamtan AR, Milakara D, Czech T, Barth M, Knosp E, Beisteiner R
J Neurol Neurosurg Psychiatry (JNNP) 2005 Aug; 76(8):1152-7; 2010 IF 4.791
FMRI reveals functional cortex in cases of inconclusive Wada testing
Lanzenberger R, Wiest G, Geissler A, Barth M, Bruck J, Ringl H, Wöber C, Gartus A, Baumgartner C, Beisteiner R
Clinical Neurology and Neurosurgery 2005 Feb; 107(2):147-151; 2010 IF 1.636
Influence of fMRI smoothing procedures on replicability of fine scale motor localization
Geissler A, Lanzenberger R, Barth M, Tahamtan A, Milakara D, Gartus A, Beisteiner, R
NeuroImage 2005 Jan; 24(2): 323-331, 2010 IF 5.932